Drug Report History
Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.
The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.
Version v13-FR | Version v12-EN | |
---|---|---|
Language | French | English |
Date Updated | 2018-08-29 | 2018-08-29 |
Drug Identification Number | 00035017 | 00035017 |
Brand name | ISOPTO ATROPINE | ISOPTO ATROPINE |
Common or Proper name | ISOPTO ATROPINE 1% SOLUTION 5ML | ISOPTO ATROPINE 1% SOLUTION 5ML |
Company Name | ALCON CANADA INC | ALCON CANADA INC |
Ingredients | ATROPINE SULFATE | ATROPINE SULFATE |
Strength(s) | 1% | 1% |
Dosage form(s) | SOLUTION | SOLUTION |
Route of administration | OPHTHALMIC | OPHTHALMIC |
Packaging size | 5ML | 5ML |
ATC code | S01FA | S01FA |
ATC description | MYDRIATICSAND CYCLOPLEGICS | MYDRIATICSAND CYCLOPLEGICS |
Reason for discontinuation | Other (Please describe in comments) | Other (Please describe in comments) |
Anticipated discontinuation date | ||
Actual discontinuation date | 2018-03-13 | 2018-03-13 |
Remaining supply date | 2018-12-31 | 2018-12-31 |
Discontinuation status | Reversed | Reversed |
Discontinuation decision reversal | yes | yes |
Tier 3 Status | No | No |
Information on remaining supply | ||
Company comments | WILL NOT BE DISCONTINUED. Product is now available. Novartis Pharmaceuticals has moved to a tight and timely management of inventory for continuity of supply of Isopto Atropine throughout Canada | WILL NOT BE DISCONTINUED. Product is now available. Novartis Pharmaceuticals has moved to a tight and timely management of inventory for continuity of supply of Isopto Atropine throughout Canada |
Health Canada comments |